U.S. settles with Teva over keeping generic drugs off market
The agency has said that the deals cost consumers billions annually in higher drug costs.
A TEVA Pharmaceutical Industries building is seen in Jerusalem last year. (Ammar Awad/Reuters)(photo credit: AMMAR AWAD / REUTERS)